Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moderna, Inc. Director's Dealing 2024

Dec 2, 2024

30610_dirs_2024-12-02_8fe45570-a6b4-4d8c-bd63-5d97bf29dfbb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2024-11-27

Reporting Person: Mock James M (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-11-27 Common Stock M 1326 Acquired 10831 Direct
2024-11-27 Common Stock M 329 Acquired 11160 Direct
2024-11-27 Common Stock M 1326 Acquired 12486 Direct
2024-11-29 Common Stock S 1420 $42.7891 Disposed 11066 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-27 Performance Stock Units $ M 1326 Disposed Common Stock (1326) Direct
2024-11-27 Restricted Stock Units $ M 329 Disposed Common Stock (329) Direct
2024-11-27 Restricted Stock Units $ M 1326 Disposed Common Stock (1326) Direct

Footnotes

F1: Performance stock units convert into common stock on a one-for-one basis.

F2: Restricted stock units convert into common stock on a one-for-one basis.

F3: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs and PSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and do not represent a discretionary trade by the Reporting Person.

F4: 25% of the shares subject to this performance stock unit award vested on May 31, 2024 upon determination of achievement of the performance criteria, with the remainder vesting in three (3) equal installments on August 27, 2024, November 27, 2024 and February 27, 2025.

F5: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

F6: 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.